Back to search

Article

Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRC

2022-05-31

Abstract excerpt

<title>Abstract</title> <p>Gastric cancer is the fourth leading cause of cancer deaths worldwide. Most patients are diagnosed in the advanced stage, and inadequate therapeutic strategies and the high recurrence rate leads to the poor 5-year survival rate. Therefore, effective chemoprevention drugs for gastric cancer are urgently needed. Repurposing clinical drugs is an effective strategy for cancer chemopreventio...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
bd029203-7f1d-5f69-a036-fc510dedc5ad
DOI
10.21203/rs.3.rs-1628199/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Vortioxetine hydrobromide inhibits the growth of gastric cancer cells in vivo and in vitro by targeting JAK2 and SRCDOI 10.21203/rs.3.rs-1628199/v1
Select a neighboring publication to make it the new centre.